Opens in a new tab

NanoString Technologies v 10x Genomics (CoA, 10 December 2024)

Date10 December 2024
CourtCoA
DivisionLuxembourg (LU)
Type of actionAppeal RoP220.2
Registry referenceAPL_593120/2023 · ORD_598533/2023
PartiesNanoString Technologies Germany GmbH, NanoString Technologies Inc., NanoString Technologies Netherlands B.V. v. 10x Genomics, Inc., President …

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In an order of 10 December 2024 (UPC_CoA_470/2023), given in German, the Court of Appeal set aside the Munich Local Division’s order of 5 December 2023 imposing a penalty payment of €100,000 on the NanoString companies for breach of a preliminary injunction obtained by 10x Genomics and the President and Fellows of Harvard College (EP 4 108 782). As the injunction itself had been set aside by the Court of Appeal on 26 February 2024, the penalty lost its legal basis, including for breaches committed before that date. The Court laid down the principle that setting aside a first-instance order has retroactive effect. In practice, a party enforcing a preliminary injunction through penalty payments bears the risk of the injunction being set aside on appeal.

Facts and procedure

On 19 September 2023 the Munich Local Division granted provisional measures against NanoString, backed by penalty payments of up to €250,000 per infringement. On 10x’s application under Article 82(4) UPCA and Rule 354.4, it imposed on 5 December 2023 a penalty of €100,000, finding among other things an offer to perform the patented method in NanoString’s Amsterdam laboratory and offers of CosMx products. On 26 February 2024 the Court of Appeal set aside the order of 19 September 2023 and dismissed the application for provisional measures. On 6 August 2024 it rejected 10x’s request to reopen those proceedings. The parties waived an oral hearing.

The applicable law

Article 75(1) UPCA and Rule 242.1 govern the effect of an appeal decision setting aside a first-instance decision. The Court read them in the light of Directive 2004/48, in particular Article 3, and of the mechanisms compensating the defendant where provisional measures are lifted (Articles 7(4) and 9(7) of the Directive, Articles 60(9) and 62(5) UPCA), referring to the CJEU judgment in Mylan v Gilead (paragraph 11).

Question

Can a penalty payment order stand, for earlier breaches, once the preliminary injunction on which it was based has been set aside on appeal?

Decision

Setting aside a first-instance order has, as a rule, retroactive effect: the order set aside is to be regarded as having had no legal effect from the outset. Setting aside a preliminary injunction backed by penalty payments therefore removes the legal basis for any subsequent penalty order, even in respect of breaches before the set-aside (paragraph 10). This is consistent with the balance struck by the Directive between protecting intellectual property rights and the rights of the defendant (paragraph 11). Since the impugned order rested on the injunction of 19 September 2023, it was set aside and 10x’s applications dismissed (paragraph 12). 10x bears the costs at both instances (paragraph 13), and the Registry was instructed to refund to NanoString the amount paid to comply with the order (paragraph 14).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 60(9), 62(5), 75(1) and 82(4)
Rules of Procedure
Rules 242.1 and 354.4
Directive 2004/48/EC
Arts 3, 7(4) and 9(7)
Case law cited
10x Genomics v NanoString, Munich Local Division, 19 September 2023, 10x Genomics v NanoString, Munich Local Division, 5 December 2023, NanoString v 10x Genomics, Court of Appeal, 26 February 2024, 10x Genomics v NanoString, Court of Appeal, 6 August 2024, CJEU, 11 January 2024, Mylan v Gilead, C-473/22

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Appeal RoP220.2
Outcome (Dhenne Avocats summary)
L’annulation en appel d’une injonction provisoire a un effet rétroactif et prive de base légale l’astreinte de 100 000 euros prononcée sur son fondement, même pour des manquements antérieurs. La somme versée est restituée.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 108 782
Compositions and methods for analyte detection
recorded proprietor: Harvard University
Mentioned in the analysis (role not qualified)
Also mentioned in 18 other decision(s): NanoString Technologies v 10x Genomics (CoA, 11 March 2024) · 10x Genomics v NanoString (CFI, 19 September 2023) · 10x Genomics v Bruker Spatial Biology (CFI, 11 April 2025) · 10x Genomics v Vizgen (CoA, 11 March 2025) · 10x Genomics v Vizgen (CoA, 5 March 2025) · 10x Genomics v Vizgen (CFI, 20 December 2024) · 10x Genomics v Vizgen (CFI, 1 November 2024) · 10x Genomics v Vizgen (CFI, ORD_49363/2024, 24 October 2024)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.